Abstract IA08: Synthetic viability due to BRCA2 and PARP1 loss

作者
Shyam K. Sharan
出处
期刊:Molecular Cancer Research [American Association for Cancer Research]
卷期号:15 (4_Supplement): IA08-IA08
标识
DOI:10.1158/1557-3125.dnarepair16-ia08
摘要

Abstract It is very well established that BRCA1 and BRCA2 deficient cells are hypersensitive to PARP inhibitors (PARPi) due to synthetic lethality. Because Parp1 parylates proteins involved in a wide range of biological processes, we hypothesized that inhibiting PARP activity may have detrimental effect on cells that are HR proficient and do not undergo synthetic lethality. We have demonstrated that although Brca2 null ES cells are not viable, they can survive after ES cells expressing a conditional allele of Brca2 are treated with olaparib prior to Cre-mediated deletion of the conditional allele. We also found that while Parp1 loss does not rescue the HR defect, surprisingly, it rescues the MRE11-mediated degradation of stalled replication forks associated with BRCA2 loss. Interestingly, we found that reducing MRE11 activity/levels also rescues the lethality of Brca2ko/ko ES cells. Similar to the ES cells, we observe fork protection in mouse B-cells deficient in Parp1 and Brca2 as well as in human MCF10A cells. This unexpected functional interaction between BRCA2 and PARP1 that results in synthetic viability can have profound clinical implications: use of PARP inhibitors for cancer prevention in BRCA-mutation carriers is being explored based on the assumption that PARPi would be innocuous in normal cells. Our findings raise concerns that when patients are treated with PARPi, not only are the tumor cells killed, but normal cells can also be affected. In BRCA-mutation carriers, the majority of the cells that lose the wild-type allele undergo cell cycle arrest or apoptosis unless they acquire additional mutations in genes (the identity of which are unknown) that bypass such a response. Our work provides strong evidence that Parp1 inhibition contributes to the viability of BRCA2 deficient cells, a key step in the transformation of a normal cell to pre-neoplastic state. We have genetic evidence to show that Parp1 deficiency can contribute to tumorigenesis in mice. We found a significant increase in tumorigenesis in Brca2 conditional knockout mice (cko/cko) with K14Cre on a Parp1 heterozygous background compared to those on a Parp1 wild-type background. Citation Format: Shyam K. Sharan. Synthetic viability due to BRCA2 and PARP1 loss [abstract]. In: Proceedings of the AACR Special Conference on DNA Repair: Tumor Development and Therapeutic Response; 2016 Nov 2-5; Montreal, QC, Canada. Philadelphia (PA): AACR; Mol Cancer Res 2017;15(4_Suppl):Abstract nr IA08.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
大个的应助被WangDongdong采纳,获得10
刚刚
1秒前
1秒前
ZIYE的应助被lianyi采纳,获得10
1秒前
doudou发布了新的文献求助10
2秒前
丹皮小姐发布了新的文献求助10
3秒前
APIU发布了新的文献求助10
3秒前
4秒前
lzh发布了新的文献求助10
4秒前
无聊的棒棒糖完成签到,获得积分10
4秒前
buqi发布了新的文献求助50
4秒前
5秒前
elysia发布了新的文献求助10
6秒前
共享精神的应助被Elle采纳,获得10
7秒前
8秒前
任风完成签到,获得积分10
8秒前
8秒前
molihuakai的应助被聪明雨灵采纳,获得10
8秒前
8秒前
香蕉凌蝶完成签到,获得积分10
9秒前
马世杰发布了新的文献求助10
9秒前
科研通AI6.4的应助被tlc_191026采纳,获得10
10秒前
华仔的应助被yangang采纳,获得10
11秒前
12秒前
cheems发布了新的文献求助10
12秒前
12秒前
礼拜一完成签到 ,获得积分20
13秒前
buqi发布了新的文献求助50
13秒前
13秒前
doudou完成签到,获得积分10
14秒前
牛牛发布了新的文献求助10
14秒前
14秒前
daomaihu发布了新的文献求助100
14秒前
SZU_Julian完成签到,获得积分10
14秒前
慕青的应助被xx采纳,获得10
15秒前
风吹麦浪的应助被江海共余生采纳,获得10
15秒前
16秒前
xzy666的应助被快乐的妙松采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183449
求助须知:如何正确求助?哪些是违规求助? 9572834
关于积分的说明 21827509
捐赠科研通 7780646
什么是DOI,文献DOI怎么找? 3434016
关于科研通互助平台的介绍 2558189
邀请新用户注册赠送积分活动 2480371